Tag: opioid

June 8, 2020
Growing Pains: The Shift from Opioids to Other Pain Therapies

With opioid utilization decreasing, what concerns do other pain therapies pose?

READ MORE
December 7, 2019
How Declining Opioid Use Impacts Claims and Outcomes

According to the CWCI, reduced opioid utilization from 2010-2017 saved $6.5 billion in California comp costs.

READ MORE
November 7, 2019
HHS Publishes Opioid Tapering and Discontinuation Guideline

The guideline covers a wide range of relevant topics, including pain, dosing, dangerous co-prescribing, comorbidities, and more.

READ MORE
November 1, 2019
The Economic Impact of Non-Medical Opioid Use

The Society of Actuaries published a report that claims the economic burden of the opioid epidemic was $631 billion from 2015-2018.

READ MORE
September 9, 2019
FDA Postpones Opioid Approval Decision

NKTR-181 (loxicodegol) was to receive an approval decision by August 29th, but a reevaluation of opioid policy has resulted in a delay.

READ MORE
September 3, 2019
Johnson & Johnson to Pay $572 Million in Opioid Trial

An Oklahoma judge found the drug maker to be partially responsible for the harm of the opioid epidemic.

READ MORE
August 2, 2019
WCRI Reports on Interstate Variation in Dispensing Opioids

While many states report fewer opioid prescriptions, MME levels vary more significantly by state.

READ MORE
July 9, 2019
First-Time Generics Approved for Two Pain Medications

Generic versions of Ultram (tramadol hydrochloride) tablets and Dyloject (diclofenac sodium) injections have been approved by the FDA.

READ MORE
July 8, 2019
NCCI Examines Impact of the ODG Formulary in Arizona and Tennessee

While the utilization of opioids and other problematic drugs decreased, similar drops were seen in states without closed formularies.

READ MORE
June 9, 2019
FDA Reexamines Discontinued Drug for New Pain Applications

Orphengesic Forte has received a decision date of August 14, 2019.

READ MORE
lockenvelopephone-handsetmenucross-circle